Viewing StudyNCT02643303



Ignite Creation Date: 2024-05-06 @ 7:59 AM
Last Modification Date: 2024-10-26 @ 11:54 AM
Study NCT ID: NCT02643303
Status: COMPLETED
Last Update Posted: 2022-12-02
First Post: 2015-12-18

Brief Title: A Study of Tremelimumab and IV Durvalumab Plus Poly-ICLC in Subjects With Biopsy-accessible Cancers
Sponsor: Ludwig Institute for Cancer Research
Organization: Ludwig Institute for Cancer Research

Organization Data

Organization: Ludwig Institute for Cancer Research
Class: OTHER
Study ID: LUD2014-011
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Ludwig Institute for Cancer Research
Lead Sponsor Class: OTHER
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
MedImmune LLC INDUSTRY
Cancer Research Institute New York City OTHER